SCYNEXIS
SCYX
#7943
Rank
HK$3.15 B
Marketcap
HK$39.76
Share price
4.75%
Change (1 day)
623.60%
Change (1 year)

Earnings for SCYNEXIS (SCYX)

Earnings in 2026 (TTM): -HK$0.2 Billion

According to SCYNEXIS's latest financial reports the company's current earnings are HK$20.34 Million. In 2025 the company made an earning of -HK$66.16 Million, an increase over its 2024 earnings that were of -HK$0.16 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for SCYNEXIS from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.2 Billion190.95%
2025 -HK$66.16 Million-58.45%
2024 -HK$0.16 Billion-128.88%
2023 HK$0.55 B-212.84%
2022 -HK$0.49 Billion87.15%
2021 -HK$0.27 Billion-41.74%
2020 -HK$0.45 Billion8.41%
2019 -HK$0.42 Billion205.58%
2018 -HK$0.14 Billion-25.66%
2017 -HK$0.19 Billion-31.73%
2016 -HK$0.27 Billion19.9%
2015 -HK$0.23 Billion111.45%
2014 -HK$0.11 Billion-27.82%
2013 -HK$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Galmed Pharmaceuticals
GLMD
-HK$87.17 Million-54.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
HK$2.32 B-1,309.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-HK$0.72 Billion 271.17%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-HK$0.33 Billion 70.91%๐Ÿ‡บ๐Ÿ‡ธ USA